🇺🇸 FDA
Patent

US 7927821

Methods of screening for compounds which bind G protein-coupled receptors

granted A61KA61K31/403A61K31/4155

Quick answer

US patent 7927821 (Methods of screening for compounds which bind G protein-coupled receptors) held by Takeda Pharmaceutical Company Limited expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/403, A61K31/4155, A61K31/4523, A61K38/1796